These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 34397764)
1. Immunohistochemical Expression Status of p53, CD44v9, and Ki-67 in a Series of Fallopian Tube Lesions of High-grade Serous Carcinoma. Sugimoto S; Uchiyama T; Kawahara N; Ohbayashi C; Kobayashi H Int J Gynecol Pathol; 2021 Sep; 40(5):419-426. PubMed ID: 34397764 [TBL] [Abstract][Full Text] [Related]
2. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma]. Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294 [No Abstract] [Full Text] [Related]
3. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors]. Wen J; Shi JL; Shen DH; Chen YX; Song QJ Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451 [TBL] [Abstract][Full Text] [Related]
4. Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma. Novak M; Lester J; Karst AM; Parkash V; Hirsch MS; Crum CP; Karlan BY; Drapkin R Gynecol Oncol; 2015 Oct; 139(1):104-11. PubMed ID: 26206555 [TBL] [Abstract][Full Text] [Related]
5. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
6. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma. Mittal N; Srinivasan R; Gupta N; Rajwanshi A; Nijhawan R; Gautam U; Sood S; Dhaliwal L Indian J Pathol Microbiol; 2016; 59(4):481-488. PubMed ID: 27721278 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma. Kuhn E; Kurman RJ; Soslow RA; Han G; Sehdev AS; Morin PJ; Wang TL; Shih IeM Am J Surg Pathol; 2012 Dec; 36(12):1826-34. PubMed ID: 22892598 [TBL] [Abstract][Full Text] [Related]
8. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388 [TBL] [Abstract][Full Text] [Related]
10. IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis. Wang Y; Li L; Wang Y; Yuan Z; Zhang W; Hatch KD; Zheng W J Exp Clin Cancer Res; 2014 Jul; 33(1):60. PubMed ID: 25038792 [TBL] [Abstract][Full Text] [Related]
11. Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium. van der Ploeg P; Uittenboogaard A; Bosch SL; van Diest PJ; Wesseling-Rozendaal YJW; van de Stolpe A; Lambrechts S; Bekkers RLM; Piek JMJ Gynecol Oncol; 2022 Apr; 165(1):114-120. PubMed ID: 35123772 [TBL] [Abstract][Full Text] [Related]
12. Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma. Kuhn E; Kurman RJ; Sehdev AS; Shih IeM Int J Gynecol Pathol; 2012 Sep; 31(5):416-22. PubMed ID: 22833080 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of precursor lesions (P53 signature, SCOUT, STIL, STIC) in fallopian tubes resected for non-neoplastic causes. Tewari S; Misra V; Kumar V; Mishra RR; Yadav K; Paridhi ; Sangma H Indian J Pathol Microbiol; 2022; 65(3):610-616. PubMed ID: 35900489 [TBL] [Abstract][Full Text] [Related]
14. Characterization of Primary Cilia in Normal Fallopian Tube Epithelium and Serous Tubal Intraepithelial Carcinoma. Abdelhamed ZA; Ryan TA; Fuller M; Coulson-Gilmer C; Abdelmottaleb DI; Wang TL; Kaun JC; Wang P; Hutson R; Wilkinson N; Bell SM; Johnson CA Int J Gynecol Cancer; 2018 Oct; 28(8):1535-1544. PubMed ID: 30095490 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma. Norris EJ; Zhang Q; Jones WD; DeStephanis D; Sutker AP; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK J Pathol; 2019 Jul; 248(3):352-362. PubMed ID: 30883751 [TBL] [Abstract][Full Text] [Related]
16. The genomic trajectory of ovarian high-grade serous carcinoma can be observed in STIC lesions. Cheng Z; Ennis DP; Lu B; Mirza HB; Sokota C; Kaur B; Singh N; Le Saux O; Russo G; Giannone G; Tookman LA; Krell J; Barnes C; McDermott J; McNeish IA J Pathol; 2024 Sep; 264(1):42-54. PubMed ID: 38956451 [TBL] [Abstract][Full Text] [Related]
17. High-grade Serous Carcinoma Occurring in a Serous Cystadenoma on the Background of a Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesion: A Case Report With Literature Review. Novikov FV; Anufriev AG; Efremov GD Int J Gynecol Pathol; 2024 Nov; 43(6):626-630. PubMed ID: 38661558 [TBL] [Abstract][Full Text] [Related]
18. The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer. Kobayashi H; Iwai K; Niiro E; Morioka S; Yamada Y; Ogawa K; Kawahara N Biomed Rep; 2017 Sep; 7(3):209-213. PubMed ID: 28811894 [TBL] [Abstract][Full Text] [Related]
19. Aneuploidy Landscape in Precursors of Ovarian Cancer. Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050 [TBL] [Abstract][Full Text] [Related]
20. Changes in the Extracellular Matrix Are Associated With the Development of Serous Tubal Intraepithelial Carcinoma Into High-Grade Serous Carcinoma. van der Steen SCHA; Bulten J; Van de Vijver KK; van Kuppevelt TH; Massuger LFAG Int J Gynecol Cancer; 2017 Jul; 27(6):1072-1081. PubMed ID: 28333845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]